Results 211 to 220 of about 394,701 (235)

Successful treatments of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome-related macular edema and exudation by intravitreal aflibercept injection in a senile patient: A case report. [PDF]

Medicine (Baltimore)
Tung HF, Wu JS, Chen SN, Chen SN.
europepmc   +1 more source

Macular oedema in Kawasaki syndrome [PDF]

, 2018
Aebi-Ochsner, Christine, Garweg, Justus, Suter, Claudia, Villiger, Reto   +3 more
core  

Imaging Features of Retinal Vasculitis and/or Retinal Vascular Occlusion after Brolucizumab Treatment in the Postmarketing Setting. [PDF]

Ophthalmol Sci
Grewal DS, Wykoff CC, D'Souza D, Jehl V, Alecu I, Jaffe GJ.   +5 more
europepmc   +1 more source

Corrigendum to "Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee". [PDF]

J Vitreoretin Dis
europepmc   +1 more source

Rare anterior uveitis entities [PDF]

, 2014
Garip-Kuebler, Aylin
core  

Some of the next articles are maybe not open access.

Related searches:

Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events

Science Translational Medicine, 2023
In October 2019, Novartis launched brolucizumab, a single-chain variable fragment molecule targeting vascular endothelial growth factor A, for the treatment of neovascular age-related macular degeneration. In 2020, rare cases of retinal vasculitis and/or
Anette C. Karle, Matthias B. Wrobel, S. Koepke, Michael Gutknecht, Sascha Gottlieb, B. Christen, Tina Rubic-Schneider, I. Pruimboom-Brees, X. Leber, M. Scharenberg, B. Maciejewski, O. Turner, Chandrassegar Saravanan, Francois Huet, A. Littlewood-Evans, A. Clemens, C. Grosskreutz, J. Kearns, Pawan Mehan, R. Schmouder, V. Sasseville, D. Brees   +21 more
semanticscholar   +1 more source

Retinal Vasculitis Associated with SAPHO Syndrome Responding to Treatment with Adalimumab

Ocular immunology and inflammation, 2023
Purpose To report a case of bilateral retinal vasculitis successfully managed with adalimumab in a patient with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome.
C. Iwahashi, T. Itami, Masuo Sakamoto, S. Kusaka   +3 more
semanticscholar   +1 more source

Occlusive retinal vasculitis: novel insights into causes, pathogenesis and treatment.

Current Opinion in Ophthalmology, 2022
PURPOSE OF REVIEW Occlusive retinal vasculitis (ORV) has a large differential diagnosis and varied therapeutic approaches. This review highlights existing and novel causes and treatment options for ORV.
Sruthi R. Arepalli, A. Thomas
semanticscholar   +1 more source